SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Value Investing
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Micah Lance who wrote (59825)4/25/2018 8:44:30 PM
From: Spekulatius  Read Replies (1) of 78794
 
Re APVO - I still own a few shares. Not and expert in biotech, but the company seems to execute quite well, with one product in the market (with very moderate revenues, but growth potential) and one promising Phase II cancer drug, as well as preclinical candidates. They do seem have the cash to last another 2 years without having to raise equity.

I am kind of out of depth with this investment, but I feel like continuing to roll the dice here. It’s only a roughly 0.25% position, so no big deal if it does not work out.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News